Aggrecan-based extracellular matrix is an integral part of the human basal ganglia circuit

Neuroscience

Volumn 151, Issue 2, 2008, Pages 489-504

  Bruckner G ^a   Morawski, M ^a,b   Arendt, T ^a  

^a Medical Faculty   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

basal ganglia; chondroitin sulfate proteoglycan; Parkinson's disease; perineuronal net; synapse

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AGGRECAN; HYALURONIC ACID; LINK PROTEIN; SCLEROPROTEIN;

ADULT; AGED; ARTICLE; BASAL GANGLION; DOPAMINERGIC NERVE CELL; EXTRACELLULAR MATRIX; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNEURON; MALE; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA; SYNAPSE; WHITE MATTER;

AGED; AGED, 80 AND OVER; AGGRECANS; AUTOPSY; BASAL GANGLIA; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; NERVE NET; PARKINSON DISEASE; TISSUE FIXATION;

EID: 37849038541     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.10.033     Document Type: Article

References (102)

1. Adams I., Brauer K., Arélin C., Härtig W., Fine A., Mäder M., Arendt T., and Brückner G. Perineuronal nets in the rhesus monkey and human basal forebrain including basal ganglia. Neuroscience 108 (2001) 285-298
2. Asher R.A., Scheibe R.J., Keiser H.D., and Bignami A. On the existence of a cartilage-like proteoglycan and link proteins in the central nervous system. Glia 13 (1995) 294-308
3. Atherton J.F., and Bevan M.D. Ionic mechanisms underlying autonomous action potential generation in the somata and dendrites of GABAergic substantia nigra pars reticulata neurons in vitro. J Neurosci 25 (2005) 8272-8281
4. Augood S.J., Waldvogel H.J., Münkle M.C., Faull R.L.M., and Emson P.C. Localization of calcium-binding proteins and GABA transporter (GAT-1) messenger RNA in the human subthalamic nucleus. Neuroscience 88 (1999) 521-534
5. Baig S., Wilcock G.K., and Love S. Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease. Acta Neuropathol 110 (2005) 393-401
6. Bekku Y., Su W.D., Hirakawa S., Fässler R., Ohtsuka A., Kang J.S., Sanders J., Murakami T., Ninomiya Y., and Oohashi T. Molecular cloning of Bral2, a novel brain-specific link protein, and immunohistochemical colocalization with brevican in perineuronal nets. Mol Cell Neurosci 24 (2003) 148-159
7. Belichenko P.V., Miklossy J., and Celio M.R. HIV-I induced destruction of neocortical extracellular matrix components in AIDS victims. Neurobiol Dis 4 (1997) 301-310
8. Belichenko P.V., Miklossy J., Belser B., Budka H., and Celio M.R. Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jacob disease. Neurobiol Dis 6 (1999) 269-279
9. Bertolotto A., Rocca G., Canavese G., Migheli A., and Schiffer D. Chondroitin sulfate proteoglycan surrounds a subset of human and rat CNS neurons. J Neurosci Res 29 (1991) 225-234
10. Blandini F., Nappi G., Tassorelli C., and Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol 62 (2000) 63-88
11. Bolam J.P., Hanley J.J., Booth P.A.C., and Bevan M.D. Synaptic organisation of the basal ganglia. J Anat 196 (2000) 527-542
12. Braak H., and Braak E. Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult. Hum Neurobiol 5 (1986) 71-82
13. Brückner G., Brauer K., Härtig W., Wolff J.R., Rickmann M.J., Derouiche A., Delpech B., Girard N., Oertel W.H., and Reichenbach A. Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia 8 (1993) 183-200
14. Brückner G., Hausen D., Härtig W., Drlicek M., Arendt T., and Brauer K. Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease. Neuroscience 92 (1999) 791-805
15. Brückner G., Pavlica S., Morawski M., Palacios A.G., and Reichenbach A. Organization of brain extracellular matrix in the Chilean fat-tailed mouse opossum Thylamys elegans (Waterhouse, 1839). J Chem Neuroanat 32 (2006) 143-158
16. Carulli D., Rhodes K.E., Brown D.J., Bonnert T.P., Pollack S.J., Oliver K., Strata P., and Fawcett J.W. Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. J Comp Neurol 494 (2006) 559-577
17. Carulli D., Rhodes K.E., and Fawcett J.W. Upregulation of aggrecan, link protein 1, and hyaluronan synthases during formation of perineuronal nets in the rat cerebellum. J Comp Neurol 501 (2007) 83-94
18. Celio M.R., Spreafico R., De Biasi S., and Vitellaro-Zuccarello L. Perineuronal nets: past and present. Trends Neurosci 21 (1998) 510-515
19. B receptors on rat pallidosubthalamic terminals. Acta Pharm Sinica 26 (2005) 10-16
20. 28K immunohistochemistry. Brain 122 (1999) 1421-1436
21. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 (1999) 1437-1448
22. DeLong M.R., and Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 64 (2007) 20-24
23. Delpech B., Delpech A., Brückner G., Girard N., and Maingonnat C. Hyaluronan and hyaluronectin in the nervous system. In: Evered D., and Whelan J. (Eds). The biology of hyaluronan. Ciba Foundation Symposium 143 (1989), John Wiley & Sons, Chichester 208-232
24. Derouiche A., Härtig W., Brauer K., and Brückner G. Spatial relationship of lectin-labelled extracellular matrix and glutamine synthetase-immunoreactive astrocytes in rat cortical forebrain regions. J Anat 189 (1996) 363-372
25. Dityatev A., and Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat Rev Neurosci 4 (2003) 456-468
26. Dityatev A., Brückner G., Dityateva G., Grosche J., Kleene R., and Schachner M. Activity-dependent formation and functions of chondroitin sulfate-rich extracellular matrix of perineuronal nets. J Neurobiol 67 (2007) 570-588
27. Evers O., and Uylings H.B.M. An optimal antigen retrieval method suitable for different antibodies on human brain tissue stored for several years in formaldehyde fixative. J Neurosci Methods 72 (1997) 197-207
28. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
29. Galtrey C.M., Asher R.A., Nothias F., and Fawcett J.W. Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve repair. Brain 130 (2007) 926-939
30. Galtrey C.M., and Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 54 (2007) 1-18
31. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15 (1992) 133-139
32. Gerfen C.R. Indirect-pathway neurons lose their spines in Parkinson disease. Nat Neurosci 9 (2006) 157-158
33. Graybiel A.M., and Ragsdale C.W. Histochemically distinct compartments in the striatum of human, monkeys and cat demonstrated by acetylcholinesterase staining. Proc Natl Acad Sci U S A 75 (1978) 5723-5726
34. Halliday G.M., Macdonald V., and Henderson J.M. A comparison of degeneration in the motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. Brain 128 (2005) 2272-2280
35. Hamani C., Dostrowsky J.O., and Lozano A.M. The motor thalamus in neurosurgery. Neurosurgery 58 (2006) 146-158
36. Hardman C.D., McRitchie D.A., Halliday G.M., Cartwright H.R., and Morris J.G.L. Substantia nigra pars reticulata neurons in Parkinson's disease. Neurodegeneration 5 (1996) 49-55
37. Hardman C.D., Halliday G.M., McRitchie D.A., and Morris J.G.L. The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy. J Neuropathol Exp Neurol 56 (1997) 132-142
38. Härtig W., Brauer K., and Brückner G. Wisteria floribunda agglutinin-labelled nets surround parvalbumin-containing neurons. Neuroreport 3 (1992) 869-872
39. Härtig W., Derouiche A., Welt K., Brauer K., Grosche J., Mäder M., Reichenbach A., and Brückner G. Cortical neurons immunoreactive for the potassium channel Kv3.1b subunit are predominantly surrounded by perineuronal nets presumed as a buffering system for cations. Brain Res 842 (1999) 15-29
40. Hausen D., Brückner G., Drlicek M., Härtig W., Brauer K., and Bigl V. Pyramidal cells ensheathed by perineuronal nets in human motor and somatosensory cortex. Neuroreport 7 (1996) 1725-1729
41. Hikosaka O., Nakamura K., and Nakahara H. Basal ganglia orient eyes to reward. J Neurophysiol 95 (2006) 567-584
42. Hirsch E.C. Mechanism and consequences of nerve cell death in Parkinson's disease. J Neural Transm 56 (1999) 127-137
43. Hirsch E.C., Graybiel A.M., Duyckaerts C., and Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson's disease and in progressive supranuclear palsy. Proc Natl Acad Sci U S A 84 (1987) 5976-5980
44. Hobohm C., Günther A., Grosche J., Roβner S., Schneider D., and Brückner G. Decomposition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats. J Neurosci Res 80 (2005) 539-548
45. Hobohm C., Härtig W., Brauer K., and Brückner G. Low expression of extracellular matrix components in rat brain stem regions containing modulatory aminergic neurons. J Chem Neuroanat 15 (1998) 135-142
46. Hockfield S., and McKay R.D.G. A surface antigen expressed by a subset of neurons in the vertebrate central nervous system. Proc Natl Acad Sci U S A 80 (1983) 5758-5761
47. Holt D.J., Graybiel A.M., and Saper C.B. Neurochemical architecture of the human striatum. J Comp Neurol 384 (1997) 1-25
48. Horn A.K., Brückner G., Härtig W., and Messoudi A. Saccadic omnipause and burst neurons in monkeys and human are ensheathed by perineuronal nets but differ in their expression of calcium-binding proteins. J Comp Neurol 455 (2003) 341-352
49. Jellinger K.A. Recent developments in the pathology of Parkinson's disease. J Neural Transm 62 (2002) 347-376
50. Karachi C., Francois C., Parain K., Bardinet E., Tande D., Hirsch E., and Yelnik J. Three-dimensional cartography of functional territories in the human striatopallidal complex using calbindin immunoreactivity. J Comp Neurol 450 (2002) 122-134
51. Kawaguchi Y. Neostriatal cell subtypes and their functional roles. Neurosci Res 27 (1997) 1-8
52. Konigsmark B.W. Methods for the counting of neurons. In: Nauta W.H.J., and Ebbesson S.O.E. (Eds). Contemporary research methods in neuroanatomy (1970), Springer, Berlin 315-380
53. Köppe G., Brückner G., Härtig W., Delpech B., and Bigl V. Characterization of proteoglycan-containing perineuronal nets by enzymatic treatments of rat brain sections. Histochem J 29 (1997) 11-20
54. Lander C., Zhang H., and Hockfield S. Neurons produce a neuronal cell surface-associated chondroitin sulfate proteoglycan. J Neurosci 18 (1998) 174-183
55. Lévesque J.C., and Parent A. GABAergic interneurons in human subthalamic nucleus. Mov Disord 20 (2005) 574-584
56. Lou W., Guo C., Zheng J., Chen T.L., Wang P.Y., and Vertel B.M. Aggrecan from start to finish. J Bone Miner Metab 18 (2000) 51-56
57. Ma T.P. Identification of the substantia nigra pars lateralis in the macaque using cytochrome oxidase and fiber stains. Brain Res 480 (1989) 305-311
58. Ma S.Y., Rinne J.O., Collan Y., Royotta M., and Rinne U.K. A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease. J Neurol Sci 140 (1996) 40-45
59. Mai J.K., Assheuer J., and Paxinos G. Atlas of the human brain (1997), Academic Press, San Diego
60. Marinelli M., Rudick C.N., Hu X.T., and White F.J. Excitability of dopamine neurons: modulation and physiological consequences. CNS Neurol Dis Drug Targets 5 (2006) 79-97
61. Massey J.M., Amps J., Viapiano M.S., Matthews R.T., Wagoner M.R., Whitaker C.M., Alilain W., Yonkof A.L., Khalyfa A., Cooper N.G., Silver J., and Onifer S.M. Increased chondroitin sulfate proteoglycan expression in denervated brain stem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol (2007) doi: 10.1016/j.expneurol.2007.03.029.
62. Matthews R.T., Kelly G.M., Zerillo C.A., Gray G., Tiemeyer M., and Hockfield S. Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets. J Neurosci 22 (2002) 7536-7547
63. May P.J., and Hall W.C. The sources of the nigrotectal pathway. Neuroscience 19 (1986) 159-180
64. McRae P., Rocco M.M., Kelly G., Brumberg J.C., and Matthews R.T. Sensory deprivation alters aggrecan and perineuronal net expression in the mouse barrel cortex. J Neurosci 27 (2007) 5405-5413
65. McRitchie D.A., Halliday G.M., and Cartwrith H. Quantitative analysis of the variability of substantia nigra pigmented cell clusters in human. Neuroscience 68 (1995) 539-551
66. McRitchie D.A., Hardman C.D., and Halliday G.M. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol 364 (1996) 121-150
67. Medina-Flores R., Wang G., Bissel S.J., Murphey-Corb M., and Wiley C.A. Destruction of extracellular matrix proteoglycans is pervasive in simian retroviral neuroinfection. Neurobiol Dis 16 (2004) 604-616
68. Mesulam M.M., Geula C., Bothwell, and Hersh L.B. Human reticular formation: Cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J Comp Neurol 281 (1989) 611-633
69. Morawski M., Brückner M.K., Riederer P., Brückner G., and Arendt T. Perineuronal nets potentially protect against oxidative stress. Exp Neurol 188 (2004) 309-315
70. Morawski M., Meinecke C.H., Reinert T., Dörffel A.C., Riederer P., Arendt T., and Butz T. Determination of trace elements in the human substantia nigra. Nucl Inst Methods B 231 (2005) 224-228
71. Morel A., Loup F., Magnin M., and Jeanmonod D. Neurochemical organization of the human basal ganglia: Anatomofunctional territories defined by the distributions of calcium-binding proteins and SMI-32. J Comp Neurol 443 (2002) 86-103
72. Morel A., Magnin M., and Jeanmonod D. Multiarchitectonic and stereotactic atlas of the human thalamus. J Comp Neurol 387 (1997) 588-630
73. Moro E., and Lang A.E. Criteria for deep-brain stimulation in Parkinson's disease: review and analysis. Expert Rev Neurother 6 (2006) 1695-1705
74. Morris N.P., and Henderson Z. Perineuronal nets ensheath fast spiking, parvalbumin-immunoreactive neurons in the medial septum/diagonal band complex. Eur J Neurosci 12 (2000) 828-838
75. Münkle M.C., Waldvogel H.J., and Faull R.L.M. The distribution of calbindin, calretinin, and parvalbumin immunoreactivity in the human thalamus. J Chem Neuroanat 19 (2000) 155-173
76. Murakami T., and Ohtsuka A. Perisynaptic barrier of proteoglycans in the mature brain and spinal cord. Arch Histol Cytol 66 (2003) 195-207
77. Neame P.J., and Barry F.P. The link proteins. EXS 70 (1994) 53-72
78. Pahapill P.A., and Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain 123 (2000) 1767-1783
79. Parent A., Fortin M., Côté P.Y., and Cicchetti F. Calcium-binding proteins in primate basal ganglia. Neurosci Res 25 (1996) 309-334
80. Paxinos G., Huang X.F., and Toga A.W. The rhesus monkey brain in stereotaxic coordinates (2000), Academic Press, San Diego
81. Pearson J., Goldstein M., Markey K., and Brandeis L. Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 8 (1983) 3-32
82. Pizzorusso T., Medini P., Barardi N., Chierzi S., Fawcett J.W., and Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298 (2002) 1248-1251
83. Preuss T.M., Gray D., and Cusick C.G. Subdivisions of the motor and somatosensory thalamus of primates revealed with Wisteria floribunda agglutinin histochemistry. Somatosens Mot Res 15 (1998) 211-219
84. Rauch U. Extracellular matrix components associated with remodeling processes in brain. Cell Mol Life Sci 61 (2004) 2031-2045
85. Rodriguez-Oroz M., Rodriguez M., Guridi J., Mewes K., Chockkman V., Vitek J., DeLong M.R., and Obeso J.A. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain 124 (2001) 1777-1790
86. B receptors inhibit synaptic inputs to rat subthalamic neurons. Neuroscience 108 (2001) 431-436
87. Silver J., and Miller J.H. Regeneration beyond the glial scar. Nat Rev Neurosci 5 (2004) 146-156
88. Smith Y., and Kieval J.Z. Anatomy of the dopamine system in the basal ganglia. Trends Neurosci 23 (2000) S28-S33
89. Syková E. Diffusion properties of the brain in health and disease. Neurochem Int 45 (2004) 453-466
90. Tan S.K.H., Temel Y., Blokland A., Steinbusch H.W.M., and Visser-Vandewalle V. The subthalamic nucleus: From response selection to execution. J Chem Neuroanat 31 (2006) 155-161
91. Temel Y., and Visser-Vandewalle V. Targets for deep brain stimulation in Parkinson's disease. Expert Opin Ther Targets 10 (2006) 355-362
92. Tepper J.M., and Bolam J.P. Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol 14 (2004) 685-692
93. van Domburg P.H.M.F., and ten Donkelaar H.J. The human substantia nigra and ventral tegmental area. A neuroanatomical study with notes on aging and aging diseases (1991), Springer Verlag, New York
94. van Horssen J., Wesseling P., van den Heuvel L.P.W.J., de Waal R.M.W., and Verbeek M.M. Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders. Lancet Neurol 2 (2003) 482-492
95. Viapiano M.S., and Matthews R.T. From barriers to bridges: chondroitin sulfate proteoglycans in neuropathology. Trends Mol Med 12 (2006) 488-496
96. Vidal E., Bolea R., Tortosa R., Costa C., Domènech A., Monleón E., Vargas A., Badiola J.J., and Pumarola M. Assessment of calcium-binding proteins (parvalbumin and calbindin D-28K) and perineuronal nets in normal and scrapie-affected adult sheep brains. J Virol Methods 136 (2006) 137-146
97. Wakabayashi K., Mori F., and Takahashi H. Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson's disease. Parkinsonism Relat Disord 12 (2006) S92-S98
98. Waldvogel H.J., Baer K., Allen K.L., Rees M.I., and Faull R.L. Glycine receptors in the striatum, globus pallidus, and substantia nigra of the human brain: an immunohistochemical study. J Comp Neurol 502 (2007) 1012-1029
99. BR2 receptor subunits. J Comp Neurol 470 (2004) 339-356
100. Waldvogel H.J., and Faull R.L.M. Compartmentalization of parvalbumin immunoreactivity in the human striatum. Brain Res 610 (1993) 311-316
101. Yamaguchi Y. Chondroitin sulfate proteoglycans in the nervous system. In: Iozzo R.V. (Ed). Proteoglycans. Structure, biology, and molecular interactions (2000), Marcel Decker, New York 379-402
102. Yasuhara O., Akiyama H., McGeer E., and McGeer O.L. Immunohistochemical localization of hyaluronic acid in rat and human brain. Brain Res 635 (1994) 269-282